Pharmaceutical

Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency drugs in development, 2024

GlobalData tracks 6 drugs in development for Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency by six companies/universities/institutes. The top development phase for Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency is phase ii, with three drugs in that stage.

Aug 31, 2024 - 04:00
GlobalData tracks 6 drugs in development for Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency by six companies/universities/institutes. The top development phase for Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency is phase ii, with three drugs in that stage.
Read the original article

Tags:

Previous Article

Frontotemporal Dementia (FTD) drugs in development, 2024

Next Article

Siemens Healthineers to Acquire Novartis’ European Radiodiagnostic Production Ne...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Polio cases derived from new oral vaccine reported for first time

Polio cases derived from new oral vaccine reported for ...

Mar 19, 2023

STAT+: Pharmalittle: We’re reading about a Lilly obesity-drug ad, a $35 cap on inhalers, and more

STAT+: Pharmalittle: We’re reading about a Lilly obesit...

Mar 8, 2024

Dewpoint Therapeutics and Mitsubishi Tanabe link on ALS treatment

Dewpoint Therapeutics and Mitsubishi Tanabe link on ALS...

Dec 7, 2024